Literature DB >> 8416744

Immunoelectron microscopic localization of transforming growth factor beta 1 and latent transforming growth factor beta 1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells.

T Mizoi1, H Ohtani, K Miyazono, M Miyazawa, S Matsuno, H Nagura.   

Abstract

Transforming growth factor beta 1 (TGF-beta 1) is secreted as an inactive complex associated with latent TGF-beta 1 binding protein (LTBP). Tissue localization of these proteins has not been fully understood in human pathological conditions. We examined the immunohistochemical localization of TGF-beta 1 precursor (proTGF-beta 1) and LTBP in carcinomas and granulation tissue in the human gastrointestinal tract at the light and electron microscopic levels. In normal tissue, endothelial cells and granulocytes sporadically showed immunoreactivity for proTGF-beta 1, while epithelial cells were all negative. In cancer tissue, both cancer cells and stromal cells (fibroblasts, macrophages, and endothelial cells) were positive for proTGF-beta 1, more frequently in diffuse-type gastric carcinomas than in differentiated-type adenocarcinomas. Immunoelectron microscopy revealed that proTGF-beta 1 was localized in rough endoplasmic reticulum and perinuclear cisternae in fibroblasts, macrophages, and endothelial cells in cancer stroma and in fibrous granulation tissue. In contrast, the intracellular localization of proTGF-beta 1 in carcinoma cells was predominantly observed in the cytosol (cytoplasmic matrix). This finding suggests disarranged or blocked intracellular transportation of proTGF-beta 1 in cancer cells. The immunoreactivity for LTBP was not observed in the normal epithelial cells. It was localized in cancer stroma, not in cancer cells. Ultrastructurally, LTBP was located in the extracellular matrix around fibroblasts and smooth muscle cells. The intracellular immunoreactivity for LTBP was observed in rough endoplasmic reticulum of fibroblasts and smooth muscle cells, the same as in granulation tissue. These results suggest that gastrointestinal carcinoma cells produce no or a small amount of LTBP in vivo. Our investigation suggests that extensive fibrosis in both cancer stroma and granulation tissues may be promoted by TGF-beta 1 mainly secreted from stromal cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8416744

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta.

Authors:  J Saharinen; J Keski-Oja
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

2.  Adiponectin receptors are downregulated in human gastric cancer.

Authors:  Kensuke Otani; Joji Kitayama; Takao Kamei; Daisuke Soma; Hideyo Miyato; Toshimasa Yamauchi; Takashi Kadowaki; Hirokazu Nagawa
Journal:  J Gastroenterol       Date:  2010-03-25       Impact factor: 7.527

3.  Novel functional single nucleotide polymorphisms in the latent transforming growth factor-beta binding protein-1L promoter: effect on latent transforming growth factor-beta binding protein-1L expression level and possible prognostic significance in ovarian cancer.

Authors:  Tomomi Higashi; Satoru Kyo; Masaki Inoue; Hideji Tanii; Kiyofumi Saijoh
Journal:  J Mol Diagn       Date:  2006-07       Impact factor: 5.568

Review 4.  The latent transforming growth factor beta binding protein (LTBP) family.

Authors:  R Oklü; R Hesketh
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

5.  A homozygous mutation in LTBP2 causes isolated microspherophakia.

Authors:  Arun Kumar; Maheswara R Duvvari; Venkatesh C Prabhakaran; Jyoti S Shetty; Gowri J Murthy; Susan H Blanton
Journal:  Hum Genet       Date:  2010-07-09       Impact factor: 4.132

6.  Immunohistochemical study of gamma delta T cell receptor-positive cells in the capsular region of hepatocellular carcinoma: possible role in defense against expansion of carcinoma in the liver.

Authors:  K Chin; K Morise; K Kanayama; H Nagura
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

7.  Biodistribution of titanium dioxide from biologic compartments.

Authors:  Daniel G Olmedo; Deborah R Tasat; María Beatriz Guglielmotti; Rómulo Luis Cabrini
Journal:  J Mater Sci Mater Med       Date:  2008-04-04       Impact factor: 3.896

8.  Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells.

Authors:  O Shinto; M Yashiro; H Kawajiri; K Shimizu; T Shimizu; A Miwa; K Hirakawa
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

9.  Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy.

Authors:  M Yamazaki; S Minota; H Sakurai; K Miyazono; A Yamada; I Kanazawa; M Kawai
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

10.  Morphological alteration of Golgi apparatus and subcellular compartmentalization of TGF-beta1 in Golgi apparatus in gerbils following transient forebrain ischemia.

Authors:  Zhiping Hu; Liuwang Zeng; Lesi Xie; Wei Lu; Jie Zhang; Ting Li; Xiang Wang
Journal:  Neurochem Res       Date:  2007-06-13       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.